ReviewBrain, behavior, & immunity - health2026
The interaction between the immune system and the autonomic nervous system in the pathophysiology of major depressive disorder: a scoping review.
Review in Brain, behavior, & immunity - health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Major depressive disorder (MDD) has been associated with both immune dysregulation and autonomic nervous system (ANS) dysfunction, and growing evidence suggests that bidirectional interactions between these systems may contribute to depression pathophysiology. However, the existing evidence has not yet been comprehensively synthesized, limiting understanding of the ANS-immune axis in MDD. This scoping review aimed to map the literature investigating interactions between the ANS and immune system in MDD, identify methods assessing this relationship, and explore implications for stratification. Following PRISMA-ScR and Joanna Briggs Institute guidelines, a systematic search of 12 databases and trial registers was conducted through January 2026. Eligible studies included human studies examining both ANS functioning and immune markers in MDD. Data were synthesized across three ANS domains: catecholaminergic signaling, cardiac autonomic measures, and vagus nerve functioning. Twenty-five studies published between 1989 and 2025 were included. Studies on catecholamine-immune interactions reported both positive associations and null findings between catecholamines and inflammatory markers, while in vitro studies showed both suppressive and enhancing immune effects. Several studies investigating heart rate variability (HRV) have reported inverse associations between inflammatory markers and vagally mediated HRV indices, although many of these studies lacked covariate adjustment. Studies investigating vagal function and vagus nerve stimulation reported immunomodulatory effects, but these varied according to stimulation modality, duration, and participant stratification. Current evidence suggests that altered ANS functioning may be associated with immune dysregulation in MDD, but findings remain heterogeneous. Larger longitudinal studies with standardized methods are needed to clarify these ANS-immune interactions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.